Join to View Full Profile
5115 Centre Ave# UpmcPittsburgh, PA 15232
Phone+1 412-623-7955
Dr. Drappatz is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Neuro-Oncology, 2004 - 2005- Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2001 - 2004
Boston University Medical CenterInternship, Internal Medicine, 2000 - 2001
Johannes Gutenberg University of Mainz Faculty of MedicineClass of 1999
Certifications & Licensure
PA State Medical License 2011 - 2026
MA State Medical License 2004 - 2012
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014-2025
- CMS Meaningful Use Stage 1 Certification ARIA oncology information system (for Medical Oncology), Varian Medical Systems, 2015-2016
- CMS Meaningful Use Stage 1 Certification ARIA Oncology Information System (for Medical Oncology), Varian Medical Systems, 2015-2016
Clinical Trials
- A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma Start of enrollment: 2008 Aug 01
- A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma Start of enrollment: 2011 Dec 01
- Imiquimod and Tumor Lysate Vaccine Immunotherapy in Adults With High Risk or Recurrent Grade II Gliomas Start of enrollment: 2012 Oct 01
Publications & Presentations
PubMed
- 2 citationsCorticosteroid Use Before Stereotactic Brain Biopsy for Suspected Lymphoma.Maged T Ghoche, Kenji Miki, Skyler Oken, Namya Manoj, Neslihan Nisa Gecici
Neurosurgery. 2026-07-01 - 1 citationsEvaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.Patrick Y Wen, Donald A Berry, Meredith B Buxton, Howard Colman, John de Groot
Journal of Clinical Oncology. 2026-06-20 - 1 citationsTreatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data.Tulika Rudra Gupta, Mei-Yin C Polley, Robert Redd, Eudocia Q Lee, Isabel Arrillaga-Romany
Journal of Clinical Oncology. 2026-05-22
Other
- Seizures in patients with primary and metastatic brain tumorsDrappatz J, Avila EK, Wen PY
http://www.uptodate.com/contents/seizures-in-patients-with-primary-and-metastatic-brain-tumors
UpToDate, Wolters Kluwer Health - 2013-04-03 - Management of vasogenic edema in patients with primary and metastatic brain tumorsDrappatz J, Wen PY
http://www.uptodate.com/contents/management-of-vasogenic-edema-in-patients-with-primary-and-metastat
UpToDate, Wolters Kluwer Health - 2013-02-13 - Systemic therapy for brain metastasesDrappatz J, Wen PY
http://www.uptodate.com/contents/systemic-therapy-for-brain-metastases
UpToDate, Wolters Kluwer Health - 2012-12-07
Press Mentions
Classifying Childhood Brain Cancers by Immune Response May Improve Diagnostics and TreatmentsMarch 19th, 2025
Benefits of WBRT for Brain MetastasesAugust 2nd, 2019
New Molecule Found to Cross the Blood‐Brain Barrier: Reporte... : Neurology TodayFebruary 28th, 2017
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
